Kappa opioid binding sites on the R1.1 murine lymphoma cell line: sensitivity to cations and guanine nucleotides

J Neuroimmunol. 1992 Dec;41(2):223-30. doi: 10.1016/0165-5728(92)90073-t.

Abstract

The present study describes the characterization of an opioid binding site on membranes prepared from the R1.1 cell line, a murine thymoma. Specific (-)[3H]bremazocine binding was saturable, stereoselective, and limited to a single high affinity binding site with a Kd value of 15.2 +/- 1.6 pM and a Bmax value of 54.8 +/- 6.0 fmol/mg of protein. The kappa-selective alkaloids and dynorphin peptides inhibited (-)[3H]bremazocine binding with Ki values of less than 1 nM, in contrast to mu- and delta-selective ligands. The high affinity of this site for alpha-neo-endorphin and U50,488 suggests that this kappa opioid binding site resembles the kappa 1b subtype. NaCl, as well as other mono- and divalent cations, inhibited (-)[3H]bremazocine binding. In the presence of NaCl, the nucleotides GTP, GDP, and the nonhydrolyzable analog guanylyl-5'-imidodiphosphate (Gpp(NH)p) also decreased (-)[3H]bremazocine binding, suggesting that this kappa opioid binding site is coupled to a G-protein. In summary, R1.1 cells possess a single high affinity kappa opioid receptor that shares many properties with brain kappa 1b opioid receptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzomorphans / metabolism
  • Binding Sites
  • Guanine Nucleotides / pharmacology*
  • Guanylyl Imidodiphosphate / pharmacology
  • Lymphoma / metabolism*
  • Mice
  • Receptors, Opioid, kappa / analysis*
  • Receptors, Opioid, kappa / drug effects
  • Sodium Chloride / pharmacology
  • Tumor Cells, Cultured

Substances

  • Benzomorphans
  • Guanine Nucleotides
  • Receptors, Opioid, kappa
  • Guanylyl Imidodiphosphate
  • Sodium Chloride
  • bremazocine